Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Diabetes Mellitus, Type 2

• A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects With T2DM
• Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes
• A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
• A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)
• A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
• Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal, Healthy, Adult, Human Subjects Under Fasting Co
• A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes
• Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
• Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
• Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
• Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients
• Polypill for Prevention of Cardiomyopathy
• A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
• Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus
• A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions
• A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus
• ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
• Assessment of Gastric Emptying by SHR20004 in Healthy Subjects
• A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
• Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
• Precision Dosing of Metformin in Youth With T2D
• A Study of HS-20094 in T2DM Participants
• The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus
• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
• Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control
• Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
• Effect of Physical Activity on Neurogenesis in Peripheral Diabetic Neuropathy Type-II Diabetes
• Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
• Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial
• Efficacy and Safety of Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke Combined With Type 2 Diabetes Mellitus
• A Study to Evaluate the DDI of HSK7653 With Metformin
• Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
• The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
• A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
• A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.
• Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM
• The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics
• Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
• A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
• A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
• Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes
• A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
• GLUcose Transport and REnalPROtection in Chronic Kidney Disease
• A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
• Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects
• A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
• A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery
• A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
• Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
• Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes Mellitus
• A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
• Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
• A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
• Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus
• Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
• A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult Subjects
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
• A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
• A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men
• Semaglutide and Vascular Regeneration
• Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes
• Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
• Role of BCAA in Glucose Homeostasis
• Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
• Polypill Versus Metformin in New Onset Type 2 Diabetes
• A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes
• A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
• To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM
• To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus
• Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
• A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
• Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
• SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin
• A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers
• A Phase 1 Clinical Study of SIPS-2209-1 Compared to SIPS-2209-2 and SIPS2209-3 in Healthy Korean Volunteers
• Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
• High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program
• SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
• Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
• Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
• Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
• Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
• A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM
• Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.
• A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus
• Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
• NAD Augmentation in Diabetes Kidney Disease
• AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study
• Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients
• Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
• To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378
• To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
• SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency
• Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2DM)
• The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT
• Pharmacokinetics and Safety/Tolerability of CKD-379
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
• A Study of Tirzepatide (LY3298176) to Assess Glycemic Control in Adults With Type 2 Diabetes Switching From a GLP-1 RA to Tirzepatide (SURPASS-SWITCH-2)
• A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
• Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
• To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.
• Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus
• To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic Drugs
• A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186
• A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
• A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
• Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients
• A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
• A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
• Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM
• Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes
• Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Participants With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
• Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes
• Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
• A Study of LY3209590 Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
• FTIH of ECC5004 in Healthy Participants
• A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
• A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects
• COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
• Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
• A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
• A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropa
• Dapagliflozin Therapy In Cardiac Surgery
• Statin and Bone Health
• The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients
• A Study of IBI362 in Participants With Type 2 Diabetes
• Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
• Olive Leaf Extracts in the Control of Diabet
• Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
• A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus
• Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
• Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
• XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
• Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes
• The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes
• A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
• Efficacy of Trimetazidine in Diabetic Patients
• Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
• Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment
• Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
• Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
• A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
• A Study to Investigate the Effects of Renal Impairment on the Pharmacokinetics of PF-07081532
• The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes Inadequately Controlled on Metformin.
• Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin
• Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin
• Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
• The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
• Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects
• A Study of ZT002 in Healthy Participants
• A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
• A Phase 2 Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients
• A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
• Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
• Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
• A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
• MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
• A Study of LY3209590 as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
• Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)
• Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
• Pharmacokinetics and Safety/Tolerability Profile of CKD-379
• A Comparative Study of the Effect of Ayurvedic Drugs and Metformin in the Management of Diabetes Mellitus (Type II)
• Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
• A Study of Cardiovascular Events iN Diabetes Plus
• A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together
• A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage
• Canagliflozin Targeting Vascular Inflammation
• The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus
• Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
• Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM
• Impact of SGLT2 on Glucosuria in HNF1A-MODY
• Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes
• Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects
• iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
• Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.
• A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.
• First-in-human Single and Multiple Dose Trial of ATR-258
• A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
• A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
• A Research Study to See How Well CagriSema Helps People Losing Weight in People Who Have a Body Weight Above the Healthy Range and Type 2 Diabetes
• Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients
• Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
• The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
• A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-and Multiple-Ascending Subcutaneous Doses of DR10624
• A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
• Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
• Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
• A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment
• A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes
• Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects
• Canagliflozin and Myocardial Micro-perfusion
• Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
• Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.
• A Study of LY3209590 Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
• Effects of Liraglutide on Glycemia, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
• Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
• Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus
• Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?
• A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
• A Study of TG103 Injection in Type 2 Diabetes Subjects
• SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
• Evaluation of the Effect of SGLT-2 Inhibitors on Cardiac Remodeling in Post Myocardial Infarction Patients
• A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
• Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.
• Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects
• A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
• Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy
• THC Effects on Glucose in Type 2 Diabetes
• A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets
• Effects of Liraglutide, Empagliflozin and Linagliptin on the Cognitive Function in T2DM Patients With Mild Cognitive Impairment: a Multicenter, Randomized, Parallel Controlled Clinical Trial
• Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
• Fingolimod for Type 2 Diabetes Mellitus
• Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
• Olive Leaf Extracts in the Control of Cardiovascular Risk
• A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
• To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
• A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects
• Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus
• A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes
• A Study of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
• Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393
• Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
• Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components
• A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
• A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes
• "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
• A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers
• Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes
• A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
• Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus
• Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients
• AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
• Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
• Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes
• Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes
• Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
• XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
• SGLT2 Inhibition in Hemodialysis
• Safety, Pharmacokinetics, and Food Effect of PS1 in Healthy Subjects
• Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
• Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients
• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
• Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus
• Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes
• A Phase 1 Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
• A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
• Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
• A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
• A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
• Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension (ATENAS)
• Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
• Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes
• ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)
• DETERMINE: Detemir vs NPH
• A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers
• Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
• A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes
• A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects
• Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
• Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus
• To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
• Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
• Pioglitazone and Insulin Resistance in ADT
• Effect of HMP on Diabetic Microangiopaemia in T2DM
• Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
• Brown Adipose Tissue Metabolism in Type 2 Diabetes
• Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021
• A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
• Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT
• Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients
• The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Type 2 Diabetes
• Epigenetic and Microbiota Modifications
• Pharmacogenetics of Response to GLP1R Agonists
• Liraglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
• A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes
• Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes
• The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction
• A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
• A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
• Anti-diabetic Drugs and Fatty Liver Management
• SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)
• Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
• Degludec Glargine U300 Hospital Study
• Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose
• A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
• ORAL ANTIDIABETICS EFFECT ON VISCERAL FAT
• Pharmacokinetics of HR17031 Injection in Healthy Subjects
• Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
• A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBI
• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Parti
• The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
• A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period
• A Phase 1/2 Study Evaluating the Safety and Efficacy of CLBS201 in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
• The ORTIZ Study: Optimising RASi Therapy With SZC
• Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
• Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation
• Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs
• Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
• Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy
• Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver
• Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults
• The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2
• Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension
• A Study of IBI362 in Chinese Patients With Type 2 Diabetes
• Effect of GLP-1 Receptor Agonists on Trabecular Bone Score and Visceral Adiposity in Postmenopausal Women With Type 2 Diabetes Mellitus.
• A Multiple-Dose Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
• A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes
• Baseline Oral Health Study: UnCoVer the Connections to General Health
• Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes
• Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
• Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients
• Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.
• Cholecalciferol on Depressive Symptoms in Type 2 Diabetes Mellitus Patients
• Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
• Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes
• Follow-up of NAFLD Patients With MRI-PDFF
• Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes
• CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
• Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus
• A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
• Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
• Liraglutide and Peripheral Artery Disease
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Ins
• Effect of Taurine on Glycemic, Lipid and Inflammatory Profile in Individuals With Type 2 Diabetes
• Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg
• Stem Cell Therapy for Chronic Kidney Disease
• A Study of LY3437943 in Participants With Type 2 Diabetes
• Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes
• A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
• A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes
• A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 Diabetes
• Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus
• Investigational Study of Delayed Release Metformin
• Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
• Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure
• A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus
• Impact of Periodontal Therapy on Patients With Diabetes
• Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
• A Study to Evaluate the Effect of IMB-1018972 on Cardiac Energetics in Patients With Type 2 Diabetes (IMPROVE-DiCE)
• Activation of Brown Adipose Tissue Metabolism Using Mirabegron
• A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
• A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets
• Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
• A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
• MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus
• A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
• Chiglitazar Added to Metformin for Type 2 Diabetes
• Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus
• Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 Diabetes
• GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)
• A Study of TG103 in Subjects With Type 2 Diabetes
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin
• A Study to Investigate the PK and Safety of CKD-393
• A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
• A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
• Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus
• EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS.
• Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
• Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes
• Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF
• Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
• Comparison of Two Biphasic Insulin Regimens
• Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus
• Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
• A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin
• Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393
• Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH
• Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia
• A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes
• Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors
• Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
• Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy
• Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus
• A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics
• A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin
• Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
• DPP4 Inhibitor on Glycemic Variability
• The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg
• Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients
• A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
• Combined Active Treatment in Type 2 Diabetes With NASH
• The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
• The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.
• Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)
• Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2
• Treatment of GLP-1 for Diabetic Bariatric Patients
• Efficacy Assessment of Chinese Herbal Medicine Jiangtang Tiaozhi Recipe Treating Participants With Glucose and Lipid Metabolism Disturbances
• Obesity and Uric Acid Stones Study
• An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function
• A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)
• A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY
• STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT
• Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
• A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
• Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia
• Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
• A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease
• A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes
• A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
• Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe
• Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes
• A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
• Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
• A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 Diabetes
• A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine
• The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients
• HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
• A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus
• The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
• HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
• Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes
• Study on the Feasibility of Community Doctors Guided by Specialists to Use Basic Insulin
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus
• Glycemic Control After Antenatal Corticosteroids in Women With Pregestational Diabetes
• Mass Balance and Biotransformation of [14C]HSK7653 in Human
• Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With Type-2 Diabetes Mellitus
• A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
• Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
• Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19
• Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
• Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in Individuals With Recent-onset Type 2 Diabetes and Monogenic Diabetes
• A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years
• EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
• Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy
• Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
• Fenofibrate Versus Curcumin in Type 2 Diabetic Patients
• Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
• iSGLT2 in Prevention of Acute Kidney Injury in Patients With Diabetes Mellitus Undergoing CABG Extracorporeal On-Pump
• Tubular Markers in Response to Saxagliptin Therapy
• A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
• A Study of LY3493269 in Participants With Type 2 Diabetes
• Canakinumab in Patients With COVID-19 and Type 2 Diabetes
• The Effect of Donepezil on Glycemic Control in Type II Diabetics
• Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus
• Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
• Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
• Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes
• Low-Dose Pioglitazone in Patients With NASH (AIM 2)
• Sitagliptin for the Treatment of Type 2 Diabetes
• Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
• A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes
• Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
• Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
• Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
• Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before
• Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus
• A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
• 16-week Flexible vs. 8-week Semaglutide Titration
• A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen
• To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients
• Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)
• Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
• Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
• Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
• A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
• A Study of LY3502970 in Participants With Type 2 Diabetes
• Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes
• A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
• Anti-inflammatory Status in DM2 Treated Patients
• Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes
• To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants
• Exercise and GLP-1 RA on Insulin Secretion
• Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults
• High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy
• Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
• Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
• CHOlesterol Lowering and Residual Risk in Type 2 Diabetes
• The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
• TRIgyceride And Glucose Control With Epeleuton in Metabolic Syndrome Patients
• Effect of Glucocorticoid on Exogenous Insulin Antibody Syndrome
• Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
• Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09
• Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)
• Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus
• Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus
• Effects of DPP4 Inhibition on COVID-19
• Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery
• A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
• Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
• Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy
• A Study of Supaglutide in Chinese Type 2 Diabetes Patients
• Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes
• Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
• Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial
• Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)
• Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes
• Efficacy and Safety of Dapagliflozin in Acute Heart Failure
• A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes
• Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
• SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
• A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus
• Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
• A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects
• First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
• A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone
• Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity
• A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396
• REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations
• Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
• Renohemodynamic Effects of Combined empagliflOzin and LosARtan
• Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
• A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
• A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin
• Cynara Scolymus Extract for Treatment of Diabetes Mellitus Type 2
• The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes
• IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
• Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients
• A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers
• Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients
• Type 2 Diabetes Patients With Renal Impairment
• A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375
• The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes
• A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
• The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
• Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber)
• Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Melitus
• Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes
• Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers
• Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
• Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus
• Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
• Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
• Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)
• Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
• Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
• Evaluation of Drug Interactions of Saxagliptin With Sildenafil in Healthy Volunteers
• A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients
• A Study With NLY01 in Subjects With Type 2 Diabetes
• Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1
• To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia
• A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
• A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
• A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens
• Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
• A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
• A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
• Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
• Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular
• A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes
• Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
• Surgical or Medical Treatment
• Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes
• Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
• A Study to Evaluate Time in Range in Type 2 Diabetics Using Afrezza® Plus Basal Insulin Compared to Multiple Daily Injections
• DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
• Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus
• Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics
• Effect of Empagliflozin on Ventricular Repolarization.
• A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
• Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
• "The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes"
• Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus
• Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure
• Bioequivalence Study for Acarbose/Metformin FDC
• The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia
• Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
• Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
• Artificial Intelligence Assisted Insulin Titration System
• Co-administration of Thiamine Pyrophosphate and Metformin in Type 2 Diabetes
• A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
• A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
• A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
• Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
• Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
• Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.
• Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
• Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients
• A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
• A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese
• Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus
• Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
• Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Anti
• A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
• Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)
• Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
• Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects
• A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
• A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
• Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus
• A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus
• Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
• SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
• Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients
• Vortioxetine vs Sertraline in Mexicans
• Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus
• Effects of Structured Simplified Short-term Intensive Insulin Therapy on Long-term Glycemic Remission
• Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
• A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH
• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
• Effectiveness of Dapagliflozin for Weight Loss
• A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
• Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
• Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
• Efficacy of Black Seed Oil in Patients With Type 2 Diabetes Mellitus
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
• A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699
• A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
• A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before
• A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
• To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes
• Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
• The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II
• A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes
• Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes
• EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial
• A Study of LY3305677 in Participants With Type 2 Diabetes
• A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine
• SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease
• Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
• Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans
• Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
• Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin
• A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
• Uric Acid Lowering Trial in Youth Onset T2D
• Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes
• Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
• Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
• Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
• A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
• Effects of Insulin Glargine and Lixisenatide on the Brain
• Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial
• BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.
• Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus
• An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)
• Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
• A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
• A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
• Metabolic Effects of Melatonin Treatment
• Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Obese Men With T2DM and Hypogonadism
• Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
• A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
• The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375
• A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)
• Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus
• Fenofibrate in Type 2 Diabetes
• The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
• Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
• Oral Peri-operative TIming of Metformin (or) Salsalate to Improve Non-cardiac Surgery Glucose Control
• Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2
• A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
• Janagliflozin Treat T2DM Monotherapy
• Prognostic Predictors of Response to Hypoglycemic Therapy
• Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects
• Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin
• Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
• Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease
• Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive
• Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)
• RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
• A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
• Herbal Tea in the Treatment of Type 2 Diabetes Mellitus
• Type 2 Diabetic Patients Maintained on Statin Therapy
• Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2
• Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine
• A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions
• Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development
• Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
• Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
• Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)
• Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.
• Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea
• Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin
• Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise
• Rifaximin Improves Gut Dysbiosis in Insulin Resistance and Type 2 Diabetes
• Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus
• A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
• Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes
• A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• A Study of the Efficacy and Safety of Supaglutide in Healthy Participants
• PDD in Type 2 Diabetes w/wo Diastolic Dysfunction
• GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration
• Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
• The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition
• A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
• A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
• A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems
• Effect of Ertugliflozin on Cardiac Function in Diabetes
• Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
• Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
• Study of Sulphonylurea Synergy With Incretins
• Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
• Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
• A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
• A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study
• Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
• Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
• The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
• Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
• The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women
• Remission Through Early Monitored Insulin Therapy - Duration Month
• Tolerance & Responsiveness Improvement for Metformin (TRIM)
• Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
• Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2
• Insulin Treatment in Diabetic Older People With Heart Failure.
• Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)
• Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus
• Simplified Insulin Regimen for the Elderly
• Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
• Effects of Ketone Bodies on Cognition in Type 2 Diabetes
• A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
• Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes
• Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid
• Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
• A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM
• Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes
• Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.
• Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men
• Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus
• Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes
• Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
• Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
• First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.
• Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308
• A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)
• Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
• Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus
• Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes
• A Study of LY3209590 in Japanese Participants With Type 2 Diabetes
• Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
• Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg
• The Effect of Esomeprazole on Type 2 Diabetes
• A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools
• Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
• Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
• A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
• A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
• Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
• Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes
• MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus
• Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
• Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
• Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol
• Understanding the Cardiovascular Benefits of the Anti-Diabetes Medication SGLT2 Inhibitors
• A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
• Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes
• Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment
• A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
• EMPA Acute Heart Failure
• Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus
• A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated
• Regulation of Endogenous Glucose Production by Central KATP Channels
• 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes
• Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
• Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
• Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects
• Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus
• Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
• Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
• Tenelia Elderly CGMS Study(TEDDY)
• A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy
• Effects of LIraglutide on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
• Effect of Efpeglenatide on Cardiovascular Outcomes
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
• Low Dose Fat-Induced Insulin Resistance
• MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
• A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus
• A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects
• Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus
• Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
• The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin
• Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab
• Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
• A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
• Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
• Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I
• Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes
• First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.
• Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
• Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease
• Empagliflozin Effect on Glucose Toxicity
• Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
• Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents
• Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES
• Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients
• Multifactorial Intervention on Diabetes (MIDiab Study)
• Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
• Dapagliflozin Effect on Erythropoiesis and Physical Fitness
• Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
• The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
• Absolute Bioavailability Study With Bexagliflozin
• ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure
• Effect of Propolis or Metformin Administration on Glycemic Control in Patients With Type 2 Diabetes Mellitus
• Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus
• A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period
• A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease
• Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects
• High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
• Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes
• Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD
• Toujeo Versus NPH Self-titration Study
• Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
• Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2
• A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients
• A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide
• Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
• The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 Diabetes
• Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes
• A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects
• Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease
• Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
• A Study of LY3209590 in Participants With Type 2 Diabetes
• Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers
• Pharmacokinetics of Metformin Intolerance
• DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
• Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
• Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients
• Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin
• "Physiological" Insulin Scheme vs Traditional Scheme for Glycemic Control in Non-critical Hospitalized Patients With Diabetes Mellitus 2
• A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
• Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
• Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients
• Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes
• A Phase IV Study in Drug-Naive Patients With T2DM in China
• Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy
• Acetylsalicylic Acid and Type 2 Diabetes Mellitus
• A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382
• Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.
• A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus
• A Trial Comparing Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes
• Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes
• Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy
• Can Exenatide Prevent the Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
• The Interaction Between Metformin and Acute Exercise
• Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg
• Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients
• A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
• A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy
• CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)
• The Interaction Between Metformin and Physical Training
• A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
• A Randomized Controlled Trial Evaluating One Drop | Premium With Afrezza vs. One Drop | Premium Alone
• Effect of Oral Administration of a Herbarium Mixture (Guazuma Ulmifolia and Tecoma Stans) on Metabolic Profile in Type 2 Diabetic Patients
• Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity
• Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
• Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects
• An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers
• CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)
• A Study of LY900014 in Participants With Type 2 Diabetes Mellitus
• Lavender Aromatherapy on Sleep Quality and Metabolic Parameters of Type 2 Diabetic Patients With Insomnia
• Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF)
• Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
• Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
• A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
• Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM
• A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
• A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants
• Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents
• Incretin and CRTd.
• Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)
• An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
• A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2
• Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz
• Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients
• Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes
• Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes
• An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
• Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
• Liraglutide Effects on Epicardial Fat Inflammatory Genes
• Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
• Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus After Elective Percutaneous Coronary Intervention
• Empagliflozin and Sympathetic Nerve Traffic
• Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
• The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes
• Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
• A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
• Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study
• Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
• A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706
• A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus
• A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
• A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants
• Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus
• Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
• SGLT2 Inhibition in Combination With Diuretics in Heart Failure
• Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes
• A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
• A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes
• Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine
• Sotagliflozin Bioequivalence Study
• Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin
• Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)
• Creatine for Treatment of Depression Associated With Type 2 Diabetes
• Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
• Bexagliflozin Drug/Drug Interaction Study With Digoxin
• Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes
• Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin
• Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes
• PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and Treatment
• Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
• Effects of Canagliflozin on Intravascular Volume and Hemodynamics
• Effect of Metformin on Exercise-induced Lipolysis
• A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes
• Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
• Type 2 Diabetes and Ambulatory Surgery Patients
• Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor
• A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antid
• The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
• Empaglifozin in Early Diabetic Kidney Disease
• Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
• A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
• Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)
• A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus
• A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co
• PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria
• Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
• Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease
• Evaluation of Type 2 Diabetes Treatment
• Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient
• Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes
• A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure
• The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.
• SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk
• Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
• Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects
• Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
• Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
• Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
• Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
• Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes
• The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
• A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
• Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
• A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
• Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus
• The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
• Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation
• A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes
• Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care In Kisarawe, Tanzania
• Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)
• Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension
• Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects
• Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
• Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
• The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
• Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome
• A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
• EMPRA (EMPagliflozin and RAs in Kidney Disease)
• Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin
• Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)
• Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin
• Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study
• A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
• Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
• A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease
• The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients
• Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
• SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)
• Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.
• Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus
• DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients
• Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy
• Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
• Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
• A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
• A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
• The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion
• Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
• A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus
• Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
• Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus
• Glargine U300 Hospital Trial
• Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
• Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
• Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
• Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes
• Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients
• Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes
• A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients
• Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
• 1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus
• Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
• Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?
• Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
• Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
• Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)
• Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
• Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
• A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
• A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
• Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)
• Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
• Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin Treatment
• A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin
• A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin
• Dapagliflozin + Saxagliptin in a Basal-bolus Insulin Treatment
• The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes
• Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes
• Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes
• LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes
• Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
• A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
• Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
• Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
• Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?
• Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients
• Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
• A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
• A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus
• The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation
• Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes
• Effects of PCSK9 Inhibition by Evolocumab on Postprandial Lipid Metabolism in Type 2 Diabetes
• A Multi-center, Randomized, Double-blind, Active-controlled, Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia
• Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
• A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin
• A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes
• The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus
• Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
• A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
• Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus
• Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
• Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
• Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin
• Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy
• Effect of Anti-diabetic Drugs on Glycemic Variability
• Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus
• Treatment of Diabetes in Patients With Systolic Heart Failure
• Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients
• Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery
• Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.
• Cardiovascular Effects of Empagliflozine
• Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
• Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
• Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus
• The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
• A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes
• Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes
• CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes
• A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combina
• Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
• Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
• A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Inte
• Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)
• A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension
• Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
• Linagliptin Add-on to Insulin Background Therapy
• GLP-1/Basal Insulin Combination Therapy
• Genetics of Response to Canagliflozin
• The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes
• Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
• HbA1c Variability in Type II Diabetes
• Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
• Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone
• FM-SRP and Tooth Extraction Improve Type 2 Diabetes Mellitus in Periodontitis
• Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
• Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
• Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
• Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM)
• A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes
• Phase 3 Alogliptin Pediatric Study
• Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy
• Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
• A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
• A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
• Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
• Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
• JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus
• Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy
• Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
• A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
• The Effect of Non-surgical Periodontal Therapy Plus Doxycycline on HbA1c in Patients With Type 2 Diabetes Mellitus
• Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients
• Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
• Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
• Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
• Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
• Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)
• Low dosE GlibENclamide in Diabetes Part A
• Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
• CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)
• Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
• CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)
• Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes
• The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients
• Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects
• NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
• Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
• Mineralocorticoid Receptor Antagonists in Type 2 Diabetes
• Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria
• A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
• A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
• A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
• The Effect of DPP4 Inhibitor on Vasclular Healing
• Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes
• SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.
• The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
• The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion
• Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
• A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
• An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
• Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake
• A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
• Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
• Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients
• Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 Diabetes
• A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes
• A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes
• A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
• An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
• Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
• A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
• Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
• A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes
• An Extension Study of PEAK Trial
• The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes
• Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes
• Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
• A Study of LY3298176 in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
• An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2
• A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
• YH1 in Poorly Controlled Type 2 Diabetes
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
• Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
• Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes
• Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients
• Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects
• A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
• Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
• Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
• Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics
• Liraglutide for HIV-associated Neurocognitive Disorder
• Randomized Sitagliptin Withdrawal Study (MK-0431-845)
• Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
• Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
• The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®
• Study of the Efficacy and Tolerance of Oral Treatment With a Total Freeze-dried Culture of Lcr Restituo® Sachets (Lactobacillus Rhamnosus Lcr35®) on Intolerance to Metformin (Diarrhoea) in Patients With Diabetes Type 2
• Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
• SGLT2 Inhibition and Left Ventricular Mass
• Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
• An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to
• Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
• Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
• Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice
• Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
• Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes
• Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
• Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus
• May Metformin be Used in Renal Failure?
• A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy
• PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor
• Effects of Metformin in Heart Failure Patients
• Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
• Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes
• A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
• Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)
• Effect of GLP-1 on Angiogenesis
• A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers
• A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin
• Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus
• Randomized Trial Comparing Colesevelam vs. Ezetimibe
• Renoprotective Effects of Dapagliflozin in Type 2 Diabetes
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2
• Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus
• Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
• The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP
• A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation
• An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp
• Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
• Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
• Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
• Effect of Sitagliptin on Progression of Coronary Intermediate Lesion
• A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
• TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.
• Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
• Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers
• Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan
• Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
• 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin
• Effect of DPP4 Inhibition on Vasoconstriction
• GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes
• Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
• Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes
• Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents
• Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study
• A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)
• A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
• Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus
• A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®
• A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers
• Canagliflozin-Mealtime Insulin Rescue
• Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
• A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy
• Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
• Effects of Tianqi Capsule on Glucose Variability in Patients With Type 2 Diabetes.
• A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
• ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
• Effect of Dapagliflozin on Inflammation and Endothelial Function
• Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
• Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
• A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes
• Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan
• Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes
• Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study
• Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
• Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
• SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
• Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus
• Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA
• A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
• Effect of Evogliptin on Bone Metabolism in Human
• Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
• Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
• Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo
• Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes
• Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
• Antipsychotics and Risk of Hyperglycemic Emergencies
• Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
• Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
• Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
• Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)
• Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)
• Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control
• Tenelia Triple Combination Study
• A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers
• Foxiga Korea Local Phase 4 Study
• Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)
• A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism
• Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome
• A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus
• A Multi-center 12-week Study of HMS5552 in T2DM
• Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga
• An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus
• Bexagliflozin Efficacy and Safety Trial
• A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
• A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
• Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus
• Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes
• A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD
• Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
• Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
• Effect of Gelofusine on GLP1-receptor Imaging
• Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
• Study of HTD4010 in Healthy Volunteers
• Tofogliflozin GLP-1 Analogue Combination Trial
• Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
• Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental Study
• Sitagliptin Therapy and Kinetics of Inflammatory Markers
• Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With
• Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes
• Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
• High Potency Statins and the Risk of Diabetes
• Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
• A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes
• Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
• A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Dis
• The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, in Type 2 Diabetes Mellitus.
• Glucose Response, Excursions And Treatment (GREAT) Study
• A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
• BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)
• The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
• Effect of Dapagliflozine on Systemic and Renal Endothelial Function
• Alkaline Diet for Insulin Sensitivity
• A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
• Heart Rate Variability in Response to Metformin Challenge
• Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes
• A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
• Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
• A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
• Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
• Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus
• Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients
• Saxagliptin and Cardiac Structure and Function
• Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes
• Efficacy and Safety of Lobeglitazone Versus Sitagliptin
• Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects
• Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
• Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients
• Incretin-based Drugs and Acute Pancreatitis
• Incretin-based Drugs and Pancreatic Cancer
• Vildagliptin Versus Dapagliflozin on Glucagon
• Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
• Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
• Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy
• Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
• Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function
• Linagliptin's Effect on CD34+ Stem Cells
• Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
• Effect of Dapagliflozin on Glycemic Variability
• Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)
• Incretin-based Drugs and the Risk of Heart Failure
• Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
• A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients
• Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
• A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
• Glargine Versus NPH in Patients With Chronic Kidney Disease
• A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)
• Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
• Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
• Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus
• Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
• Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects
• Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus
• Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
• Ghrelin and Beta Cell Function in Diabetes
• the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin
• Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
• An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients
• Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
• TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus
• Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin
• Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus
• Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin
• Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
• A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
• A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
• Memory Aid by Intranasal Insulin in Diabetes (MemAID)
• A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes
• A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)
• Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients
• Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
• Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
• The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
• Add Glucokinase Activator to Target A1c
• Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology
• Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients
• Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion
• Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus
• A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus
• Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
• Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus
• Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content
• Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01
• A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers
• Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes
• Safety, Tolerability and PK of Imeglimin in Japanese Volunteers
• Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
• The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
• A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
• Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus
• A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)
• The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients
• The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients
• Fatty Liver Study in Patients With Type II Diabetes
• The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers
• A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
• The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers
• Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
• Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
• Novel Type 2 Diabetes Mellitus Preventive Therapies
• Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients
• Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients
• Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
• Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
• Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin
• Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
• Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)
• A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
• ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD
• Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
• Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
• A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
• An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus
• Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications
• Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
• Adult Subjects With Uncontrolled Type 2 Diabetes
• Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes
• The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study
• Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
• Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
• Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
• IL-1RA, Acute Exercise, and Beta-cell Function
• Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
• Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia
• Hartmann's Solution and Normal Saline in Type II Diabetes Patients
• Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
• Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
• Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
• A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus
• Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM
• To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
• Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
• A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
• The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients
• Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine
• A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy
• Trial for People With Established Type 2 Diabetes During Ramadan
• Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
• Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects
• The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study
• An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin
• Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM
• Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
• Determinants of Diabetes Remission After Gastric Bypass Surgery
• Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
• A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD
• Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Contr
• Study of REGN1193 in Patients With Type 2 Diabetes Mellitus
• Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
• Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin
• Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
• Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
• A Clinical Trial to Study the Effect of Lycopene in Patients With Gum Disease and type2 Diabetes Mellitus
• Sitagliptin and Glucagon Counterregulation
• Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
• A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
• Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes
• Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
• Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
• Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus
• Influence of Diabetes on Tramadol Pharmacokinetics
• Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
• 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately
• Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects
• Linagliptin as Add on to Basal Insulin in the Elderly
• Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes
• Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients
• Dapagliflozin Effects on Epicardial Fat
• The Practical Evidence of Antidiabetic Combination Therapy in Korea
• Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
• Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
• Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)
• Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus
• Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM
• Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
• Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus
• Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State
• The Inova Type 2 Diabetes Mellitus Study
• Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes
• Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
• Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
• Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
• Diagnostic Biomarkers Related to Periodontal Disease Activity in Diabetic
• Diabetes & Vardenafil
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease
• Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes
• A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes
• Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function
• A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
• Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.
• The Effects of Hypoglycaemia in People With Type 2 Diabetes
• A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
• Redox Imbalance and the Development of Cystic Fibrosis Diabetes
• A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
• TOFO Insulin Combination Trial
• Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
• A Study to Compare Insulin Pump With Conventional Treatment in Type 2 Diabetes
• A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics
• Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
• Correlation Between Plasma- and Endothelial DPP-4 Activity
• Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)
• Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
• Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia
• Internet Monitoring vs Medication to Control Blood Sugar in Type 2 Diabetes
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes
• BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus
• 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
• Pioglitazone Tablets Specified Drug-use Survey
• The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones
• Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin
• A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
• A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus
• Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
• Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
• Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes Mellitus
• Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
• Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
• A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Mal
• A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477
• A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects
• Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
• A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects
• Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.
• Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus
• Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment
• A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
• Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
• Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes
• PK/PD Study of U-500 Regular Insulin
• A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
• A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
• Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
• Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II
• Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
• Glycemic Durability After Metformin Failure
• Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin
• Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.
• A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes
• A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral An
• Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
• Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
• Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
• Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
• Amiloride for Resistant Hypertension
• Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients
• Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
• A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
• A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India
• Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)
• Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
• PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
• A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
• A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
• Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes
• Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
• A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Furth
• Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients
• Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
• Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone
• Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus
• Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus
• Safety Evaluation of Adverse Reactions in Diabetes
• A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus
• Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
• DPP-4 Inhibition, Incretins and Islet Function
• Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes
• Clinical Trial for PB-119 in Healthy Subjects (Phase I)
• Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment
• Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes
• Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
• A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
• Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects
• A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
• Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus
• A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
• Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
• Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"
• Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and E
• Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
• Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM
• Efficacy Study of Metformin Glycinate on Postprandial Lipemia
• Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy
• Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes
• Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)
• A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
• The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006)
• Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
• Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
• Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
• A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)
• Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
• Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
• A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
• A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin
• A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin
• Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes
• Use of Sitagliptin to Decrease Microalbuminuria
• Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes
• Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus
• Acarbose, Postprandial Hypotension and Type 2 Diabetes
• Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
• Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
• Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
• A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus
• Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
• Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
• The Efficacy of Bariatric Surgery Compared to Medical Therapy in Controlling Type2 Diabetes Mellitus in Patients With Non Morbid Obesity.
• Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria
• Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)
• A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
• Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin
• A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
• Glycemia in Diabetic Elders Trial
• Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy
• Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients
• Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment
• Metabolic Effects of Hydroxychloroquine
• A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
• Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus
• Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients
• Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
• Study on Lixisenatide and Counterregulation to Hypoglycemia
• A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
• Laser Treatment for Onychomycosis in Diabetes
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mul
• Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
• Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
• Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
• Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis
• Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes
• Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
• Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
• A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)
• Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
• Arginase Inhibition in Ischemia-reperfusion Injury
• Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
• A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2
• Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients
• The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
• A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)
• Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus
• Linagliptin Inpatient Trial
• Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"
• Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
• Drug-drug Interaction Study(Lobeglitazone, Warfarin)
• Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus
• Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
• A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes
• Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
• Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
• Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
• A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
• Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)
• A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
• Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
• Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes
• Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®
• Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
• Fasiglifam 25 mg BID vs 50 mg QD
• The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes
• Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
• A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
• Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients
• Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
• A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers
• Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
• Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)
• Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery
• A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes
• Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes
• A Study of the Effectiveness and Safety of SP2086 to Treat Type 2 Diabetes
• Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes
• The Effect of Linagliptin on Mitochondrial and Endothelial Function
• Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
• Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes
• A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)
• The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
• A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
• A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
• Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides
• Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
• Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea
• Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
• Effects of Different Types of Anesthesia on Stress Response in Laparoscopic Gastric Bypass for Type 2 Diabetes Mellitus
• Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
• A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
• A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
• Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
• Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Diseas
• Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
• A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
• Effect of Exenatide on Liver and Heart Fat and Inflammation
• Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
• A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes
• A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin
• Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
• Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus
• Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
• Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"
• Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"
• Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects
• Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
• Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
• Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
• A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test
• Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
• Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"
• Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes
• ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
• Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin
• Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
• Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets
• Multiple Dose Study Of PF-05231023 In Obese Adult Subjects
• Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus
• Liraglutide Hospital Discharge Trial
• Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes
• Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
• A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
• Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus
• GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice
• Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
• Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment
• IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus
• PMS of Trazenta on the Long-term Use as Add-on Therapy
• A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea
• Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
• Triple Therapy in Type 2 Diabetic Patients
• A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
• A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)
• An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
• Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus
• Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
• Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)
• Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)
• Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients
• Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
• Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes
• Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
• Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes
• Periodontal Treatment Response in Type II Diabetic Patients
• Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery
• A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes
• An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus
• Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
• Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
• Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
• A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy
• A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy
• A Study of LY3025876 in Participants With Diabetes
• A Study of LY2405319 in Participants With Type 2 Diabetes
• Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
• A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Withou
• Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
• Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls
• A Study of Multiple Doses of LY2922470 in Participants With Diabetes
• Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
• Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
• Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes
• Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec
• Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
• A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
• Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
• A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus
• Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes
• GLP-1 and Hypoglycemia
• Multiple Ascending Dose Study in Subjects With Type 2 Diabetes
• PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients
• Metformin Treatment in Gestational Diabetes and Noninsulin Dependent Diabetes in Pregnancy in a Developing Country
• Effects of Treating Vitamin D Deficiency in Poorly Controlled Type 2 Diabetes
• Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
• A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
• MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes
• A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
• Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
• A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients
• Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms
• The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass
• The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
• A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
• OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.
• Amlexanox for Type 2 Diabetes and Obesity
• Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)
• Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
• Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
• Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus
• Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
• Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes
• Cost Effectiveness of Glargine Insulin Versus NPH Insulin
• Protein Profile of Immunoregulatory Factors in Diabetic Cataract
• Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes
• Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus
• Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes
• Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
• Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes
• Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
• Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
• Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
• An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
• A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated
• Effects of Vildagliptine and Glimepiride on Glucose Variability
• Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy
• A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects
• Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects
• Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chroni
• Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
• Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
• REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
• The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
• Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
• Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
• Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus
• Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population
• A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes
• The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
• A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
• Detection of Diffuse Scar in Patients With Diabetes
• A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
• Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease
• A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes
• Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
• Extension Study for 2993-112
• A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus
• Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d
• A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
• Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD
• Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
• A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components
• ET-blockade and Exercise-induced Vascular Adaptations in T2DM
• ET-blockade and Exercise Induced Blood Flow in T2DM
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes
• A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
• Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
• Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
• Comparison of Insulin Mix25 Versus Mix50
• Metabolic Effects of Gastrointestinal Surgery in T2DM
• The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
• Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
• Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
• Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients
• A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)
• Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
• Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
• Beta Cell Restoration Through Fat Mitigation
• Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
• A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
• Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
• Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
• Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects
• Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin
• Blood Pressure Outcomes With Liraglutide Therapy
• A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration
• Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)
• Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects
• A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
• Lipid Biomarkers for Diabetic Heart Disease
• A Single Dose Study of LY2605541 in Participants With Liver Impairment
• A Study of LY2922083 in Healthy Participants and Participants With Diabetes
• A Study of LY2922470 in Healthy Participants and Participants With Diabetes
• SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
• Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
• Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2
• GLP-1 and Microvascular Function in Type 2 Diabetes
• The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes
• Vitamin D for Established Type 2 Diabetes (DDM2)
• Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes
• A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
• A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin
• Effects of Metformin on Hepatic FFA Metabolism
• Bioequivalence Study for Acarbose / Metformin FDC
• Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers
• A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
• Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes
• Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
• Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes
• MSC and BMMNC in Type 2 Diabetes Mellitus
• Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
• ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
• A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)
• A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
• A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime
• A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy
• Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
• Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus
• A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
• Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients
• A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus
• A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes
• Evaluation of Block Duration in Type 2 Diabetes Patients
• Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes
• Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
• Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin
• Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)
• Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)
• A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
• A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)
• Physical and Chemical Study of Atherosclerosis Mechanisms
• Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled
• Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
• Efficacy of Repaglinide in Subjects With Type 2 Diabetes
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
• Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
• A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
• A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
• A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
• Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects
• Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus
• Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
• Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
• Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function
• T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
• VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
• Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans
• A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years
• A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease
• Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
• Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations
• Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability
• A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
• Effects of Resveratrol in Patients With Type 2 Diabetes
• Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
• The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
• A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes
• Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
• A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients
• A Study of Dulaglutide in Chinese Participants
• Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
• Effect of Bile Acids on GLP-1 Secretion
• A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
• Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
• Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
• The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
• Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants
• Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"
• Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
• A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
• Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
• Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
• Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
• A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects
• Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus
• Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes
• Safety and Efficacy of Insulin Aspart in Type 2 Diabetes
• Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.
• A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
• A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
• Fatty Acid Radiotracer Comparison Study in Heart Failure Patients
• Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes
• Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes
• Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
• Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus
• A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
• Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002)
• GLP-1 and Non-exercise Activity Thermogenesis in RHZ
• Along-term Study of OPC-262 in Patients With Type 2 Diabetes
• Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes
• Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
• Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes
• Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
• French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients
• Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic Patients
• A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
• Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
• Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
• Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes
• Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
• Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
• Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
• Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes
• The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
• Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
• A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)
• Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
• Diabetes Treatment With Glucobay in Combination With Sulfonylurea
• Diabetes Treatment With Glucobay in Combination With Metformin
• A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin
• The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
• Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
• The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
• Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.
• A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes
• A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes
• A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes
• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
• Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
• Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
• Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
• Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
• Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes
• Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects
• Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
• Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
• The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
• Comparison Between aPDT and Systemic Doxycycline on Non-surgical Periodontal Therapy in Type 2 Diabetics
• Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards
• Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients
• Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant
• A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)
• Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients
• Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects
• Renal Denervation in Diabetic Nephropathy
• Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients
• To Evaluate Clinical Outcome and Injection Compliance of Scilin
• DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients
• Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)
• The Effects of LY2409021 on the Liver
• Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes
• Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D
• A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
• A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
• A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)
• Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients
• Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus
• Molecular Regulation of Muscle Glucose Metabolism
• Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes
• Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes
• Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy
• A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
• Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
• Korean Post-marketing Surveillance for Onglyza®
• A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
• Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
• Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
• Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
• A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
• A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
• A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
• Phielix et al.: Hepatic Fat Content and Adipokines
• Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus
• Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes
• Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
• The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism
• Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
• Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers
• Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)
• A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
• A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)
• A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
• Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment
• A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg
• Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
• Saxagliptin and Atherosclerosis
• Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France
• Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Efficacy and Safety of Levemir® Used as Basal Insulin
• Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment
• NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria
• Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus
• Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
• Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
• Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
• A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers
• Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)
• Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus
• LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
• Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos
• The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
• Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
• An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus
• Liraglutide Use in Prader-Willi Syndrome
• Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus
• Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)
• Pantoprazole on Insulin Secretion in Diabetes
• Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
• Special Survey for Patients With Type 1 or Type 2 Diabetes
• Paediatric Subjects - Special Survey
• Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers
• A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers
• Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2)
• Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes
• Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes
• Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands
• Post Marketing Surveillance Study of Biphasic Insulin Aspart 30
• Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes
• To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately
• Efficacy and Safety of DLBS3233 in Prediabetic Patients
• Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone
• A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients
• VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus
• Effects of DPP-4 Inhibition on Triglycerides
• Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects
• Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes
• Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes
• PK Study of Dapagliflozin in Pediatric Subjects With T2DM
• Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
• A Study Of Three PF-05190457 Formulations In Healthy Volunteers
• Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients
• Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes
• Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes
• Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
• Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
• Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes
• Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
• Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
• MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes
• Study of RO6807952 in Patients With Diabetes Mellitus Type 2
• Effect of Liraglutide on Heart Frequency in Healthy Volunteers
• Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients
• Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
• A Trial of 18F-AV-133 Positron Emission Tomography (PET)
• Japanese Phase 1 Multiple Ascending Dose Study
• A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus
• Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
• A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes
• Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
• Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
• A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
• Treatment of Diabetes After Gastric Bypass With Sitagliptin
• Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
• A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes
• Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
• Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
• Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
• Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
• Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets
• Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)
• Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
• Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
• Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus
• Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
• Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
• Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
• Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
• Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
• Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes
• Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
• Adding Liraglutide to High Dose Insulin: Breaking the Cycle
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
• Proteus Sustained Behavior Change Study
• Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
• A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
• Observational Study of NovoNorm® in Subjects With Diabetes
• An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice
• Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes
• Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
• Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2
• A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus
• Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
• Development of a Fast Measurement Technique of Insulin Resistance in Human
• Observational Study With InnoLet® in Daily Clinical Practice
• Single Ascending Dose Trial in Patients With Type 2 Diabetes
• Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction
• NovoLet® Acceptance Study Within the Hospital Practise in Indonesia
• Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice
• NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
• Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
• Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers
• Surveillance Study of NovoRapid® for New Drug Re-examination
• Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers
• A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
• Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes
• An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime
• Special Survey for Type 1 or Type 2 Diabetic Patients
• Special Survey for Paediatric Subjects
• Special Survey of Production of Insulin Aspart Specific Antibody
• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes
• Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes
• Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs
• Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
• Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
• A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus
• Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
• Polyphenols and Insulin Resistance
• Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
• A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
• A First-in-Human Study of LY3009385 in Healthy Participants
• Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
• Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
• Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
• Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505
• A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes
• QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes
• Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
• Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
• Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus
• DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
• A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
• Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
• Effects of Different Early Intensive Therapies on Long-term β-cell Function
• Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia
• Early Diabetes Intervention Program
• A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects
• A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes
• A Study in Participants With Type 2 Diabetes Mellitus
• Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients
• A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
• A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes
• Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
• Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
• Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes
• A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.
• Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)
• Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure
• Shiga Microalbuminuria Reduction Trial-2
• A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart
• Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients
• Cabergoline Effect on Blood Sugar in Type 2 Diabetics
• A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
• Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin
• R230C and C230C Variants of ABCA1 and Glyburide Response
• Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes
• A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
• A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
• A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
• A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
• A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
• A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
• An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients
• Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
• Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
• Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus
• Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus
• The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
• Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
• A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy
• Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
• Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects
• A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics
• A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria
• Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control
• A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
• Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
• A Study in Patients With Type 2 Diabetes Mellitus
• The Effects of Bethanechol on Glucose Homeostasis
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemi
• A Study To Evaluate PF-05175157 In Healthy Volunteers
• A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants
• Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
• Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
• A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes
• Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus
• Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
• Liraglutide and Heart Failure in Type 2 Diabetes
• Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
• Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients
• Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
• A Study in Adults With Type 2 Diabetes
• The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes
• Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study
• Impact of Exenatide on Sleep Duration
• First Time in Human Study Using GSK2330672
• Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus
• Pharmacogenetics of Ace Inhibitor-Associated Angioedema
• Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
• Vitamin D Supplementation on Cardiovascular Risk Factors
• Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes
• A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
• A Study in Patients With Type 2 Diabetes
• A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia
• A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)
• Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
• Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
• Albiglutide Thorough ECG Study in Healthy Volunteers
• Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects
• The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes
• Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium
• Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
• Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
• Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
• INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria
• A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril
• Pioglitazone and Metformin in Diabetic Children
• Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes
• A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
• Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes
• Liraglutide Treatment to Patients With Severe Renal Insufficiency
• Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes
• Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
• Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes
• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
• A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet
• Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus
• Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina
• Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes
• Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers
• A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)
• Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes
• Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet
• Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
• Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
• A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea
• A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes Mellitus
• Thyroid Study Type 2 Diabetes Mellitus (T2DM)
• Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
• Effect of Lycopene and Isoflavones on Glucose Metabolism
• Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus
• A Comparison of Two Initial Dosing Formulas
• Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin
• A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin
• ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
• Changes in Bone Turnover With Increased Incretin Hormone Exposure
• Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
• A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients
• 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus
• Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532
• A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532
• Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus
• A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption
• Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
• Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil
• Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
• Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus
• A Study of LY2881835 in Healthy People and People With Diabetes
• A Study of RO6807952 in Patients With Diabetes Mellitus Type 2
• Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes
• A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)
• An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
• Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes
• Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes
• Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea
• A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)
• Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
• Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
• Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy
• Metformin in Women With Type 2 Diabetes in Pregnancy Trial
• Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)
• Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
• The Relationship of Hemoglobin A1c and Diabetic Wound Healing
• Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing
• Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes
• Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes
• Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
• Drug-drug Interaction Study(CKD-501, Amlodipine)
• A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases
• Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
• An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
• Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes
• Organization Program of DiabEtes INsulIN ManaGement
• Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases
• Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment
• Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
• Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
• Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes
• Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes
• A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)
• Long-term Study of KAD-1229 in Type 2 Diabetes Patients
• Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone
• Avandamet Bioequivalence Study Brazil - Fed Administration
• Drug-drug Interaction Study (CKD-501, Ketoconazole)
• Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
• Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
• A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
• Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
• Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
• Effects of Saxagliptin on Endothelial Function
• Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
• Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
• Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan
• Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan
• Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
• Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus
• Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus
• A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients
• A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment
• Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin
• Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes
• Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus
• Effects of Alogliptin on Pancreatic Beta Cell Function
• Efficacy of Insulin Lispro Mix 50/50 Therapy
• Drug to Drug Interaction Study With ASP1941 and Metformin
• Renal Impairment Study With ASP1941
• Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
• Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
• Diacerein on Insulin Secretion in Diabetes
• A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients
• Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
• Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
• An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010
• Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus
• Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
• Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus
• A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects
• Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
• Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
• Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
• Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
• Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes
• The Effect of Anakinra on Insulin Secretion
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes
• The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
• Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
• A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients
• Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)
• Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
• Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes
• Study of AC-201 in Patients With Type 2 Diabetes Mellitus
• A Study Of PF-05175157 In Healthy Volunteers
• A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus
• Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
• Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
• Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes
• LIraglutide and Beta-cell RepAir (LIBRA) Study
• JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients
• Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
• Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes
• Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
• Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan
• Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
• Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan
• Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
• Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus
• Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes
• Colesevelam for Children With Type 2 Diabetes
• Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients
• Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone
• Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea
• Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery
• Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
• A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
• A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients
• Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study
• Type 2 Diabetes Mellitus and Atherosclerosis
• Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes
• A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects
• Single Dose Escalation Study of PF-05190457 in Healthy Volunteers
• A Study of LY2608204 in Patients With Type 2 Diabetes
• A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
• Exercise and Acarbose in Type 2 Diabetes
• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
• A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients
• A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients
• A Study of LY2409021 in Patients With Type 2 Diabetes
• Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)
• Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
• Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance
• Phase 4 Study in the Elderly Patients With T2DM
• Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes
• Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus
• Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
• Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day
• Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride
• Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
• A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus
• Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
• The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co. in Glycemic Control of Diabetic Patients
• Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
• Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus
• A Study Conducted Over 3 Periods to Look at the Drug in the Body
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients
• Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus
• Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041)
• Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients
• A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients
• Trial of Different Dosages' Ge Gen Qin Lian Decoction in the Treatment of Type 2 Diabetes
• GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients
• Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes
• Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687
• Evaluation of Dapagliflozin Taken Twice-daily
• GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes
• A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)
• A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus
• Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes
• Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone
• Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy
• Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control
• Management of Type 2 Diabetes After Gastric Bypass Surgery
• Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)
• A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
• Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability
• Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
• Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
• Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
• Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
• Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
• ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination
• Comprehensive Add on Study in Japan
• Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs
• A Multiple Dose Study Of PF-05161704 In Healthy Volunteers
• Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
• Aspirin Dosing in Diabetic Patients
• Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes
• Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)
• Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
• Malignancy Meta Analysis for BRL49653
• Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea
• Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
• Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
• Glycemic Holter Study (Continuous Glucose Monitoring) -
• Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
• A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
• Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
• Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
• Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus
• Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes
• A Single Dose Study Of PF-05161704 In Healthy Volunteers
• START-J: SiTAgliptin in eldeRly Trial in Japan
• 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Week
• The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
• Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
• Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
• Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
• A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
• To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes
• Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
• A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus
• Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
• Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments
• Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals
• Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
• Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
• Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
• The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
• Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
• Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)
• Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment
• Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy
• A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus
• A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes
• Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes
• Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart
• Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
• Resveratrol in Type2 Diabetes and Obesity
• Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes
• Hypogonadism in Young Men With Type 2 Diabetes
• Exeantide in Type 2 Diabetes on Insulin
• A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes
• Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus
• Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients
• Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty
• A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
• A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
• Trial to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI135585 XX Administered as Tablet and as Solution in Healthy Volunteers
• Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
• Initiation and Titration of Amaryl
• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
• Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
• Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
• Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study
• The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
• Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
• Impact of Exenatide on Sleep in Type 2 Diabetes
• Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients
• Pharmacogenomics of Thiazolidinediones
• A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes
• BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
• Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
• A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403
• Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes
• A Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes Mellitus
• A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
• A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263
• Saxagliptin Triple Oral Therapy
• A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038)
• Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)
• Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes
• Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment
• Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.
• Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study
• A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes
• A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
• A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
• Type 2 Diabetes Haptoglobin Phenotype and Vitamin E
• Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
• Early Insulin Treatment in Patients With Latent Autoimmune Diabetes
• Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease
• Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications
• Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes
• The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
• The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
• A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus
• The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)
• Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
• Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
• Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients
• Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients
• Single Dose Study of PF-04991532 in Healthy Subjects
• Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
• A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
• Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
• A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment
• Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin
• Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
• Vascular Effects of Sitagliptin in Diabetes Mellitus
• Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus
• A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
• A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
• Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)
• The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus
• Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
• Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)
• A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers
• The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
• A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects
• INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
• Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
• Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus
• NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus
• Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
• Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes
• To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656
• Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
• Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition
• The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
• Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
• An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients
• An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .
• Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
• Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
• A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
• Role of Interleukin-6 in Exercise
• Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
• To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients
• To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
• Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects
• Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered
• Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects
• Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs
• Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
• Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control
• Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
• A Study in Participants With Type 2 Diabetes Mellitus
• An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
• Januvia Re-examination Study (MK-0431-181)
• The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients
• Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
• Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)
• A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes
• A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients
• Observational Study in Japanese Type 2 Diabetes Patients
• Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients
• Fracture Risk With Thiazolidinediones
• Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin
• A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients
• Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
• Curcumin for Type 2 Diabetic Patients
• A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy
• Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
• Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
• A Study of OPC-262 in Patients With Type 2 Diabetes
• Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin
• Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes
• Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type
• Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes
• A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus
• A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes
• Myocardial Perfusion in Type 2 Diabetes
• The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin
• A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
• A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
• Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults
• Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?
• Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria
• Sitagliptin in Prevention of Type 2 Diabetes Mellitus
• Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease
• Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
• A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects
• Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)
• A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)
• Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)
• CANVAS - CANagliflozin cardioVascular Assessment Study
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension
• A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus
• Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
• Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus
• Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
• A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
• Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus
• A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus
• Central Mechanisms That Regulate Glucose Metabolism in Humans
• A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes
• 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)
• A Study for Patients With Type 2 Diabetes
• Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes
• A Study of LY2599506 in Patients With Type 2 Diabetes
• A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus
• Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
• Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment
• INSUlin Regimens and VASCular Functions
• An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
• Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
• Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients
• A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers
• A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
• A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus
• A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics
• Self Titration With Apidra to Reach Target Study (START)
• Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes
• Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes
• Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes
• Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
• Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin
• Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes
• Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes
• Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus
• Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
• Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State
• Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation
• Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics
• An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
• A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
• Vildagliptin and Endothelium-dependent Vasodilatation
• Monotherapy Study of MP-513 in Patients With Type 2 Diabetes
• Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
• Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
• A Study of OPC-262 in Patients With Type 2 Diabetes
• Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
• Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
• Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK
• Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
• Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea
• Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone
• University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
• Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics
• Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes
• A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
• Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)
• Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity
• Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes
• A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036)
• Dapagliflozin DPPIV Inhibitor add-on Study
• Acetyl-L-Carnitine in Type 2 Diabetes
• Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes
• Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus
• Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
• A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM
• Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
• Safety Study of BMS-816336 in Healthy Male Subjects
• 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
• NOX-E36 First-in-Human (FIH) Study
• Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes
• A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine
• A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
• Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial
• 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
• Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
• Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
• Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes
• Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)
• Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes
• Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients
• A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients
• Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
• Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes
• Glucose Reduction by Early Acarbose Treatment in Basal Insulin
• Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
• CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride
• Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
• Effect of Sitagliptin on Endothelial Progenitor Cells
• Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients
• A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
• Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population
• A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
• Study of LX4211 in Subjects With Type 2 Diabetes Mellitus
• A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
• A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)
• A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
• An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes
• Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
• Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
• Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients
• Naturlose (D-Tagatose) Efficacy Evaluation Trial
• Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
• The Effects of LAF237 on Gastric Function in Type 2 Diabetes
• A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus
• A Safety Study of ARRY-403 in Patients With Type 2 Diabetes
• The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics
• The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
• Study of Multiple Doses of Saxagliptin (BMS-477118)
• Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care
• Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
• Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment
• Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy
• Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes
• Treatment Use of Generex Oral-lyn™ in Patients With Diabetes
• Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes
• Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
• Ceramide Containing Multivesicular Emulsion Application . . .
• Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus
• Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027)
• Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
• Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
• A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)
• Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function
• Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes
• A Study of LY2189102 in Patients With Type 2 Diabetes
• Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients
• Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus
• Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)
• Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients
• Effect of Sitagliptin on Postprandial Lipoprotein Metabolism
• A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers
• A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects
• Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
• Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
• Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects
• Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients
• Activity and Metformin Intervention in Obese Adolescents
• Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes
• A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment
• A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers
• Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers
• Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
• Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2
• Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects
• Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients
• Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)
• Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors
• Interleukin-1 Receptor Antagonist and Insulin Sensitivity
• Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
• Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride
• A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes
• Interaction Study SLV337/Simvastatin
• Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes
• Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes
• Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
• Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
• Metformin in Overweight Type 2 Diabetes Mellitus
• Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control
• Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg
• Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome
• A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
• To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
• Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type
• Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid
• Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy
• Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
• Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-38431055 in Healthy Male Volunteers
• A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
• Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes
• Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)
• Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects
• The OBSTACLE Hypoglycemia Study (MK-0000-158)
• Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
• TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
• Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
• A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED)
• A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients
• Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)
• Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes
• Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)
• Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
• A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
• Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia
• Therapeutic Exploratory Study of CWP-0403
• A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)
• Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events
• Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus
• Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
• 4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)
• To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions
• A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus
• "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
• Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension
• Thiazolidinedione Intervention With Vitamin D Evaluation
• Effect of Diabetes Mellitus on Cholesterol Metabolism
• A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
• Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)
• A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)
• Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
• A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes
• A Study for Participants With Type 2 Diabetes Mellitus
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus
• A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
• Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication
• A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
• A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
• Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
• Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment
• Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
• Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
• Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes
• A Safety Study of ARRY-403 in Patients With Type 2 Diabetes
• Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
• Study of the Durability of Glycemic Control With Nateglinide
• Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects
• A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
• The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
• Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes
• Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
• Evaluation of Exenatide in Patients With Diabetic Neuropathy
• Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes
• MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus
• A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes
• Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial
• The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes
• Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
• Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus
• Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.
• Observational Study on Levemir® in Obese Diabetic Patients
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease
• Safety and Efficacy of Albiglutide in Type 2 Diabetes
• Shiga Progression of Diabetes, Nephropathy and Retinopathy
• A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)
• Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
• Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia
• Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects
• Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus
• An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries
• Insulin Therapy in the Hospital Comparing Two Protocols
• Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses
• Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
• A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
• A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes
• Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
• MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
• A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus
• Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers
• Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes
• Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients
• Effect of Renal Impairment on the Pharmacokinetics of NN9535
• The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)
• Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions
• Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes
• A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
• Acarbose Cardiovascular Evaluation Trial
• Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes
• Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes
• Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes
• A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)
• A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
• Glycemic Response to Momordica Charantia in Type 2 Diabetes
• A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
• Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
• A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin
• Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes
• Veterans Inpatient Insulin Study and Transition to Outpatient Therapy
• To Evaluate 24-hr Glucose After OD vs BD AZD1656
• Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs
• Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
• Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
• Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
• Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
• Molecular Mechanisms of Type 2 Diabetes Mellitus
• Pioglitazone Versus Metformin in Type 2 Diabetes
• Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin
• Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus
• A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)
• Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
• A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
• Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes
• Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients
• Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
• A Study of Taspoglutide in Type 2 Diabetic Patients
• A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
• Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes
• Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects
• Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
• Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)
• A Study for Patients With Type 2 Diabetes Mellitus
• Exploratory Study of Iocide Oral Rinse in a Diabetic Population
• Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive
• A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
• Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
• Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes
• Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
• Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus
• Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design
• Impact of Mulberry Leaf on Type 2 Diabetes
• Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment
• Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
• A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)
• Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
• MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)
• Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
• A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.
• Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)
• To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension
• Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
• Welchol as Monotherapy for Type 2 Diabetes Mellitus
• An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes
• Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes
• 12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients
• Detemir Energy Expenditure Study
• Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes
• Insulin Glargine Combination Therapies in Type II Diabetics
• Response To Oral Agents in Diabetes (ROAD)- Pilot Study
• Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients
• Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin
• Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
• To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin
• Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)
• Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes
• Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.
• Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
• To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin
• Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus
• Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
• Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
• Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
• Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
• Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
• Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.
• Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
• Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
• Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
• Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
• Signaling Mechanisms and Vascular Function in Diabetes Mellitus
• A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator
• Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.
• The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
• Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
• A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin
• Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.
• Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months
• A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
• A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
• Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes
• An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial
• Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy
• MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).
• Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
• Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients
• BI 10773 add-on to Metformin in Patients With Type 2 Diabetes
• How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?
• The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
• Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes
• How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.
• A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake
• Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
• A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
• A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
• Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients
• A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione
• Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients
• Observational Study on Safety of Self-titration of Once Daily Levemir®
• A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
• An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
• Variation in Sulphonylurea Response in Type 2 Diabetes
• Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes
• Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes
• Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
• Vitamin D, Insulin Resistance, and Cardiovascular Disease
• Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
• Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
• Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
• Risk of Hypoglycemia in Type 2 Diabetes
• A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
• A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing.
• Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
• Bone Turnover in Type 2 Diabetes Patients
• Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes
• Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
• Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)
• Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
• "Information Technology Methodology for Patient Motivation in Diabetes Management."
• Chronotherapy With Low-dose Aspirin for Primary Prevention
• Anti-Inflammatory Effects of Pioglitazone
• MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
• A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
• The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
• Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
• Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
• Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
• GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
• Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes
• Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes
• Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®
• Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
• Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
• Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients
• Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)
• GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
• Observational Study to Evaluate the Safety of Levemir® in Diabetes
• Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes
• Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 Diabetes
• Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes
• Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
• A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes
• Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control
• Observational Study to Evaluate the Safety While Using Levemir®
• A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
• Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control
• Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial
• Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
• Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
• An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects
• The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
• Supplements for Controlling Resistance to Insulin
• Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes
• Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes
• Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
• Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes
• Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
• An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment
• Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes
• Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics
• An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment
• Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction
• A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
• Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes
• Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus
• Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin
• Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes
• Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus
• Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes
• A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients
• Efficacy of Lubiprostone in Combination With Standard PEG Preparation
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
• NIDDM and IR in Combination Therapy for CHC
• Insulin Glargine Versus Twice-Daily NPH
• Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus
• Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes
• Insulin Glargine at Bedtime or in AM Versus NPH
• Sitagliptin in Combination With Metformin and Sulfonylurea
• A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin
• Add-on to Thiazolidinedione (TZD) Failures
• Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone
• A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
• Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
• Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health
• The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes
• Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes
• Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
• Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
• A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
• Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30
• Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™
• A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy
• Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)
• Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin
• A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes
• A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
• Observational Study of Patients With Diabetes Using Levemir® FlexPen®
• Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
• How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
• A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients
• 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
• Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany
• Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
• Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast
• Glufast On Insulin Glargine Trial in Type 2 DM
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
• Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes
• Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
• Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes
• A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus
• Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)
• Observational Study to Evaluate the Safety of Levemir® in Diabetes
• Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes
• Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
• Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
• Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)
• Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins
• Pioglitazone Incretin Study
• Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
• Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
• Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
• Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes
• Japanese P III vs Voglibose and Placebo
• Severe Insulin Resistance in Patients With Type 2 Diabetes
• The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 Diabetes
• Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)
• Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects
• Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
• A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes
• An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets
• An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease
• A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
• An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes
• Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes
• Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
• Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone
• Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus
• A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy
• A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
• CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
• Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily
• Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes
• A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)
• A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
• A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
• Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes
• Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)
• Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes
• A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects
• Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes
• Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
• Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients
• A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus
• Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
• The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
• A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)
• Effect of PF-00734200 in Subjects With Type 2 Diabetes
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
• Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects
• Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment
• Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
• Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes
• Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes
• Reandron in Diabetic Men Witn Low Testosterone Level
• Beta-Cell Function After Near-Normalisation of Blood Glucose
• A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
• Near Normalisation of BG Improves the Potentiating Effect of GLP-1
• Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes
• Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes
• Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
• Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
• Antioxidant Treatment of Type 2 Diabetes
• Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus
• First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050
• U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
• TTA in Treatment of Diabetes and Dyslipidemia
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes
• A Drug Interaction Study Between Simvastatin and GSK376501
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes
• Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes
• Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
• BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes
• Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes
• Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes
• Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes
• Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy
• Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery
• Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes
• Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes
• Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
• Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
• Genetic Variation in OCT1 and Response to Metformin
• Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
• Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
• Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin
• Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes
• 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period
• Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes
• Characteristics of Glargine in Type 2 Diabetics
• Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
• Initiation of Insulin Aspart in Type 2 Diabetes
• Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients
• Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus
• Effect of Thiazolidinedione Treatment Vascular Risk Markers
• Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.
• A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes
• N-Acetylcysteine and Arginine Administration in Diabetic Patients
• Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
• Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes
• Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)
• Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil
• Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes
• 20 Week Bridging Study in Type II DM
• Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects
• Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
• Adiponectin in Obese Women With T2DN and Effects by RAS Blocker
• Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
• Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
• A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects
• Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels
• 4 Weeks Treatment of Type II Diabetic Patients With BI 44847
• AI(I)DA Acarbose and the Subclinical Inflammation
• 4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes
• Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
• VA NEPHRON-D: Diabetes iN Nephropathy Study
• Renal Impairment in Type 2 Diabetic Subjects
• Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions
• Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes
• Glycemic Optimization Treatment Study
• Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus
• Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes
• Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)
• Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus
• Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate
• 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine
• Lispro Mix 25 vs. Glargine in Type 2 Diabetics
• Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
• To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
• An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching Insulin
• Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
• Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol
• A Study for Type 2 Diabetic Patients
• Dyslipidemia in Type 2 Diabetes (0767-034)
• REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents
• Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
• Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients
• Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)
• MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)
• Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)
• MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)
• MK0767 in Type 2 Diabetes (0767-012)
• Study A - MK0767 Monotherapy Study
• MK0767 and Sulfonylurea Combination Study (0767-027)
• Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)
• MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
• An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus
• Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus
• Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
• Eze/Simva Switch Study in Diabetics (0653A-807)
• BMS-646256 in Obese and Overweight Type 2 Diabetics
• A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
• Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)
• Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus
• Phase I Multiple-Ascending Dose (Japan)
• Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.
• Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs
• Nephropathy In Type 2 Diabetes and Cardio-renal Events
• MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
• A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults
• Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
• Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus
• Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
• Comparison of Apidra to Regular Insulin in Hospitalized Patients
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
• Acute Effects of Sildenafil on Endothelial Function in People With Diabetes
• Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes
• A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone
• A Study Of BRL49653C For The Treatment Of Type 2 Diabetes
• Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
• Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels
• Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition
• The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD
• Safety Study of ISIS 325568 in Healthy Volunteers
• A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin
• Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus
• Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
• Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
• Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
• A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
• A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
• A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
• An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
• Glucose and Lipid Metabolism on Antipsychotic Medication
• Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
• Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
• Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
• 18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes
• Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes
• A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)
• Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes
• An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)
• Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)
• Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
• Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
• Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes
• Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes
• Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control
• A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers
• Testosterone for Peripheral Vascular Disease
• Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
• A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.
• A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers
• A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers
• Study of INT-747 in Patients With Diabetes and Presumed NAFLD
• A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function
• A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers
• Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin
• Rosiglitazone on Microalbuminuria in Type 2 Diabetics
• Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
• Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
• Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes
• Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus
• Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
• Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
• Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart
• Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
• Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
• Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)
• Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs
• Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
• A Study for Patients With Type 2 Diabetes Mellitus
• Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia
• DOMME Dose Optimization Multicentric Mexican Evaluation
• Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics
• Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study
• Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)
• Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin
• Study of Rivoglitazone in Type 2 Diabetes Mellitus
• A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus
• MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)
• Comparison Between Pioglitazone and SES With type2 DM
• A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)
• A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)
• Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
• Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes
• HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)
• Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
• Dose-Range Finding Study for MK0893 (0893-008)
• Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise
• Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug
• Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects
• A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
• Effects of Colesevelam HCl On Bile Acid Kinetics
• Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
• A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
• Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy
• A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
• 12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
• Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
• Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes
• Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes
• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes
• A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin
• A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
• Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
• Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
• Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy
• Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus
• The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus
• Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia
• Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes
• A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.
• A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
• A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.
• Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
• Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus
• A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes
• Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea
• Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea
• A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects
• Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes
• Sitagliptin in the Elderly
• Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)
• A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes
• Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus
• Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
• Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin
• Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women
• Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes
• Medication in Early Diabetes (MED) Study
• The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
• A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.
• Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)
• A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
• A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus
• Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
• Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes
• Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
• Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
• Experimental Studies of the Effects of Caffeine on Glucose Regulation
• A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study
• Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
• An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)
• Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
• A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks
• Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
• Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes
• Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
• Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus
• Therapeutic Effects of Berberine in Patients With Type 2 Diabetes
• Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
• Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes
• A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
• Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
• LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus
• Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
• Effect of Urtica Dioica on Glycemic Control in Patients With Type 2 Diabetes Mellitus
• Beta-Cell Function and Sitagliptin Trial (BEST)
• A Study for Patients With Diabetes Mellitus (IOPA)
• Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus
• Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
• To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.
• This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
• The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
• Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
• Metformin for the Treatment of Diabetes in Pregnancy
• Study of Renal Blood Flow During Human Endotoxemia
• Type 2 Diabetes and the Effect of Probiotics
• Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
• Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls
• Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
• A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)
• Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes
• Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
• Lantus Versus Levemir Treat-To-Target
• A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
• Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
• "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM
• Vitamin D Supplementation to Patients With Type 2 Diabetes
• A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes
• A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
• Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients
• The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
• Initial Combination With Pioglitazone Study (0431-064)
• Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes
• Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone
• Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
• Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
• Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
• Sitagliptin Added-on to Insulin Study (0431-051)
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
• Acetylcarnitine and Insulin Sensitivity
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
• Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)
• Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
• Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
• A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®
• Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes
• Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes
• A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
• A Study of Aleglitazar in Patients With Type 2 Diabetes
• Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)
• A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
• Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
• Insulin Glargine "All to Target" Trial
• Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes
• A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
• Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes
• Safety and Efficacy of Exenatide as Monotherapy
• Double-Blind Study of Miglitol in Japanese With type2 Diabetes
• Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes
• A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.
• RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
• Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)
• Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes
• A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
• Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus
• Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
• Effect on Weight Loss of Exenatide Versus Placebo
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
• A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
• Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes
• Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus
• MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
• MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)
• GW823093C For The Treatment Of Type 2 Diabetes Mellitus
• Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.
• A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
• To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes
• A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
• Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes
• A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
• The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes
• Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715
• Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
• Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
• Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
• The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus
• Olmesartan Medoxomil and Diabetic Nephropathy
• Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
• Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
• Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment
• Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus
• Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy
• Insulin Glulisine in Type 2 Diabetic Patients
• A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
• Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
• Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
• AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes
• Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
• A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
• Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
• Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement
• In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
• The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
• Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus
• Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
• Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes
• A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes
• Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
• A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes
• A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes
• A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
• Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
• LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus
• A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
• Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
• Jikei Optimal Insulin Therapy in Type 2 Diabetes
• A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese Men
• Insulin Glargine in Type 2 Diabetic Patients
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
• Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
• Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
• Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients
• A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
• Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
• Lantus Effect on Myocardial Glucose Metabolism in T2
• Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
• AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
• Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
• Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
• Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
• Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
• A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
• Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment
• Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
• Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
• Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
• Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
• Effect of Pioglitazone on Ambulatory Blood Pressure
• Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients
• Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea
• CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
• Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study
• Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
• To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
• Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
• The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
• A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion
• Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria
• Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
• To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
• A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes
• Irbesartan in Type 2 Diabetes
• A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
• Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)
• Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
• Insulin Glargine in Type 2 Diabetes Mellitus
• Insulin Glulisine in Type 2 Diabetes Mellitus
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
• Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
• A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM
• Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus
• A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)
• Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
• Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes
• Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus
• Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)
• Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist
• A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus
• Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction
• A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia
• GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes
• Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
• BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
• Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
• A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone
• Moderate Alcohol Intake Among Patients With Type 2 Diabetes
• To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
• GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
• Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917
• Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus
• Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients
• MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)
• Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM
• Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)
• Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
• Chromium and Insulin Action
• Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
• A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus
• Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
• Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes
• Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease
• GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
• Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes
• The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
• Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes
• DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril
• The Use of Cilostazol in Patients With Diabetic Nephropathy
• Insulin Glargine in Type 2 Diabetes Mellitus
• ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.
• OPAL - Insulin Glulisine, Diabetes Mellitus
• Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
• Insulin Glargine in Type 2 Diabetes
• Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
• A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
• A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
• Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes
• Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
• ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus
• C-Reactive Protein (CRP) in Obese Diabetic Women
• Dose Response Study in Japanese Patients
• GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate
• A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
• In-patient Study in Patients With Type 2 Diabetes Mellitus
• Insulin Glargine During and After the Period of Fasting in Ramadan
• Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients
• A Study In Patients With Type 2 Diabetes Mellitus
• Markers and Mechanisms of Vascular Disease in Type II Diabetes
• The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
• GALLANT 4 Tesaglitazar vs. Glibenclamide
• The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
• Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.
• Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
• GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes
• GALLANT 22 Tesaglitazar vs. Placebo
• GALLANT 2 Tesaglitazar vs. Placebo
• GALLANT 8 Tesaglitazar Add-on to Metformin
• GALLANT 7 Tesaglitazar Add-on to Sulphonylurea
• Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
• US Inhaled Insulin Dose Titration Study
• Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
• GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
• AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus
• Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
• Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
• Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes
• A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
• GIP: Glucose-dependent Insulinotropic Peptide
• SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
• A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1
• A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes
• A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
• Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
• Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus
• Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
• A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes
• Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
• Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus
• Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin
• A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy
• A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin
• A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin
• A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy
• A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet
• Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus
• Acute Metabolic Effects of LAF 237 in Type 2 Diabetics
• GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes
• ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
• GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
• Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina
• Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus
• Rosiglitazone-Induced Weight Gain
• Canadian Trial of Dietary Carbohydrates in Diabetes
• Actos Now for Prevention of Diabetes (ACT NOW)
• GALLANT 5 Tesaglitazar Versus Metformin
• GALLANT 6 Tesaglitazar vs. Pioglitazone
• Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment
• A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus
• Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
• Janssen - Glucose Regulation/Risp/Olanz
• Pfizer/IVGTT/Ziprasidone/Olanzapine
• Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
• Rationale and Design for Shiga Microalbuminuria Reduction Trial
• Study In People With Type 2 Diabetes
• Preferred Treatment of Type 1.5 Diabetes
• Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs
• Local Registration Trial in China Humalog Mix 50
• Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
• Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
• Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes
• Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
• Olmesartan Medoxomil in Diabetes Mellitus
• Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.
• Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
• Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
• Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes
• Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes
• Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone
• Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings
• Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients
• Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes
• Insulin Glulisine in Diabetes Mellitus, Type 2
• Opposing Step-by-step Insulin Reinforcement to Intensified Strategy
• A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
• Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
• Metabolic Effects of Alcohol
• Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
• A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects
• Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin
• MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
• Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)
• Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy
• Ezetimibe and Simvastatin in Dyslipidemia of Diabetes
• Efficacy and Safety of ATL-962 in Obese Diabetics
• Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
• Free Fatty Acids and Vascular Function in Subjects With Diabetes
• Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes
• WelChol® and Insulin in Treating Patients With Type 2 Diabetes
• LANN-study: Lantus, Amaryl, Novorapid, Novomix Study
• Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients
• WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes
• Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes
• WelChol® With Metformin in Treating Patients With Type 2 Diabetes
• Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes
• Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus
• A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes
• Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
• To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.
• Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus
• Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
• Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
• Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
• Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
• Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%
• Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
• Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
• Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
• Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
• Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
• Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
• An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
• Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
• Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus
• Hospital In-Patient Insulin Study
• Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
• A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
• Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)
• The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)
• An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)
• Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
• Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance
• A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)
• Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)
• Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients
• Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
• Rosiglitazone Plaque Study
• South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus
• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
• Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes
• Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes
• Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet
• A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
• A New Oral Treatment For Type II Diabetes Mellitus
• A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
• A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
• Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
• Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes
• Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
• Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
• A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
• Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes
• Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
• Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
• Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)
• Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
• Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes
• Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
• Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
• MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)
• Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes
• Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus
• Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
• INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
• Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia
• Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%
• A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
• A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
• Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
• Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
• Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)
• Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
• Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
• Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
• Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
• Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
• Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes
• NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
• An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
• Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes
• An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)
• An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)
• Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)
• Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)
• Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
• Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
• Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
• Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
• Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)
• Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
• Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.
• The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
• A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics
• Pilot Study of Vedic Medicine for Type 2 Diabetes
• An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes
• Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
• Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
• Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus
• Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
• Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
• Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
• Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
• Efficacy and Safety In Poorly Controlled Type 2 Diabetics
• Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione
• Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
• Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
• Evaluation of the Effect of Pramlintide on Satiety and Food Intake
• Evaluation of the Bioavailability of Pramlintide
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
• Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
• A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
• Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
• Ginkgo Biloba Extract and the Insulin Resistance Syndrome
• Obese Patients With Type 2 Diabetes
• NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes
• Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
• Diabetes Prevention Program
• Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
• Study of the Effects of Vitamin C on Patients With Type 2 Diabetes
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)